Skip to Main Content

Author Details

Adam B Weiner
Northwestern University Feinberg School of Medicine
2013
68
18
PMIDPaper TitleJournal TitlePublished Year
36863416Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.Int J Radiat Oncol Biol Phys2023
35568781High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments.Prostate Cancer Prostatic Dis2023
37060201A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.Cancer2023
36723856Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
34226663A transcriptomic model for homologous recombination deficiency in prostate cancer.Prostate Cancer Prostatic Dis2022
35641398First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature.Eur Urol Oncol2022
35333400Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.Cancer2022
34158596Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate.Prostate Cancer Prostatic Dis2022
34035460Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate.Prostate Cancer Prostatic Dis2022
32873919Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study.Prostate Cancer Prostatic Dis2021
33795875A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation.Nat Cell Biol2021
33882145Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis.Cancer2021
33906801Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial.Clin Genitourin Cancer2021
33568675Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes.Nat Commun2021
33705232Editorial Comment.J Urol2021
34081322It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety?Cancer2021
32343403Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men.Cancer2020
37317377The Cost of Prostate Biopsies and their Complications: A Summary of Data on All Medicare Fee-for-Service Patients over 2 Years.Urol Pract2020
31746656Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort.J Urol2020
31738121Editorial Comment.J Urol2020
31790787Willingness to Participate in Home Screening for Urologic Cancers in the General Population: An Online Survey of Over 1400 Adults.Urology2020
32599760Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.J Clin Med2020
32936794Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer.PLoS One2020
32588523Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort.Int J Urol2020
32280026Medicaid Expansion Did not Improve Time to Treatment for Young Patients With Metastatic Renal Cell Carcinoma.Clin Genitourin Cancer2020
32471792Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review.Eur Urol Oncol2020
32399975Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.Int J Cancer2020
30528221Inflammatory Bowel Disease and the Risk of Prostate Cancer.Eur Urol2019
31242050Editorial Comment.J Urol2019
31468212Quality of Life-Focused Decision-Making for Prostate Cancer.Curr Urol Rep2019
31351589Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.Urol Oncol2019
31515456Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.Clin Cancer Res2019
31286275Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm.Curr Treat Options Oncol2019
31200845Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.Eur Urol Oncol2019
31151679Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.Eur Urol2019
30535336Contemporary Comparison of Open to Robotic Prostatectomy at a Veteran's Affairs Hospital.Mil Med2019
30611643National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.Urol Oncol2019
29338913Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).Urol Oncol2018
29852180The Influence of Decision Aids on Prostate Cancer Screening Preferences: A Randomized Survey Study.J Urol2018
30224197"Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate Cancer.Eur Urol2018
30059668Editorial Comment.J Urol2018
30489310n = 1.Acad Med2018
29406054Prostate Cancer: A Contemporary Approach to Treatment and Outcomes.Med Clin North Am2018
29620960Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy.J Endourol2018
29558547Robotic-Assisted vs Laparoscopic Radical Nephrectomy.JAMA2018
29153624The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).Urol Oncol2018
29343911Oncologic outcomes in patients with nonurothelial bladder cancer.Indian J Urol2018
27626903Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database.Cancer2017
29541579Radiographic hemithorax white-out following percutaneous nephrolithotomy.Urol Case Rep2017
  • 1 - 50 of 68

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 17
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 14
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 27
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 23
Dell Medical School, The University of Texas at Austin
Career Start Year 2010
Number of shared co-authors 2
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 7
University of Alberta
Career Start Year 2007
Number of shared co-authors 1
St. Antonius Hospital
Career Start Year 2007
Number of shared co-authors 3
University of Oxford
Career Start Year 2007
Number of shared co-authors 6
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 12
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 18
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 29
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 33
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 25
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 23
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 3
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 7
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 11
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 23
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 14
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 8
University of Toronto
Career Start Year 1989
Number of shared co-authors 23
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 26
Monash University
Career Start Year 1988
Number of shared co-authors 13
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 37
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 43

Collaborators

Northwestern University Feinberg School of Medicine
Co-authored papers 24
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 9
Johns Hopkins University School of Medicine
Co-authored papers 7
Veracyte Inc.
Co-authored papers 6
Veracyte inc.
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
University of California los angeles
Co-authored papers 4
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
University of California los angeles
Co-authored papers 3
UCSF Medical Center-Mount Zion
Co-authored papers 3
University of Michigan Medical School.
Co-authored papers 3
Northwestern University
Co-authored papers 3
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 3
The Institute of Cancer Research
Co-authored papers 2
Thomas Jefferson University Hospital
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
university of california los angeles
Co-authored papers 2
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
Shiley Eye Institute, University of California
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 2
New York-Presbyterian Hospital, Weill Cornell Medical Center
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 1
Northwestern University
Co-authored papers 1
University of California-Los Angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1